<DOC>
	<DOCNO>NCT00486252</DOCNO>
	<brief_summary>The primary objective evaluate Intraocular pressure reduce effect Xalatan 3 month . The secondary objective study efficacy parameter treatment 3 month</brief_summary>
	<brief_title>Non Interventional Study Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>Unilateral bilateral open angle glaucoma ocular hypertension ( IOP ( Intraocular Pressure ) ≥ 21 mmHg diagnosis ) . Naive patient ( prior antiglaucoma pharmacological surgical treatment ) patient betablockers therapy failure Visual acuity ( best correct ) equal good 6/6 closed/barely open anterior chamber angle history acute angle closure glaucoma . history antiglaucoma surgical treatment ( Argon Laser Trabeculoplasty and/or ocular filter surgical intervention ) . ocular surgery ( globe eye ) , inflammation/infection within 3 month prior baseline visit . ( Applies fellow study eye . ) abnormal ocular condition symptom prevent patient enter study , investigator 's clinical judgement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>